Rhapsody targeted mrna abseq kit

Ended Purchase Order Awarded Last action

Contract number
75N90024P00165
Awardee
Awarding agency
Obligated
$11,672

Award facts

Contract value 100% obligated
$11,671.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Franklin Lakes, NJ 07417, USA

Award details come from SAM.gov/FPDS.

About this award

Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center. Valued at eleven thousand six hundred seventy-one dollars and sixty cents ($11,671.60), this award is for the RHAPSODY Targeted mRNA ABSEQ Kit. Delivery is required by February 23, 2024. As a manufacturer and supplier of medical devices, instruments, reagents, and related products, BD will provide the requested diagnostic testing reagents to the NIH Clinical Center in Franklin Lakes, New Jersey under the terms of this purchase order. No set-aside designation was used for this competitive award to the for-profit organization.

Quick answers

Who was awarded contract 75N90024P00165?

75N90024P00165 was awarded to Becton, Dickinson And Co by NIH Clinical Center (National Institutes of Health) on January 23, 2024.

How much is contract 75N90024P00165 worth?

The government has obligated $11,672 on 75N90024P00165.

Was contract 75N90024P00165 competed?

The extent of competition for 75N90024P00165 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award